Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor

Part of paid clinical trials in San Diego, California.

Sponsor
DexCom, Inc.
Study ID
NCT07681375
Phase
PHASE1
Status
Active Not Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Basal insulin — DRUG
    daily basal insulin dose
  • Dexcom Continuous Glucose Monitoring (CGM) — DEVICE
    Dexcom Continuous Glucose Monitoring (CGM) Sensor

Study Details

To evaluate the feasibility of the DexBasal Study System

Key Dates

First listed
Jul 2, 2026
Start date
Apr 11, 2023
Status verified
Jun 2026
Primary completion
Jan 16, 2026
Completion
Jan 15, 2027

Study Design

Enrollment
45 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY

Arms

  • Other: Dexbasal
    Subjects initiating basal insulin therapy or on basal insulin therapy maintenance and benefit from transitioning to a study-specific type of basal insulin within 72 hours of Phase 1.

Primary Outcome Measure

Measurement of participant safety while using the DexBasal Study System [ Time Frame: Day 10 up to 8 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
San Diego Family Care (SDFC)San DiegoCalifornia92111-

Find similar trials in San Diego, CA

Nationwide
Type 2 diabetes trialsEndocrinology trialsMetabolic health trialsWeight loss trials
By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
San Diego Family Care (SDFC)· San Diego, CA

Related Studies